Talk about "medical marijuana."—Researchers at the the Scripps Research Institute report that the chief active ingredient in marijuana, "THC and its analogues may provide an improved therapeutic for Alzheimer's disease." In tests, THC handily beat the current FDA-approved Alzheimer's medications tacrine and donepezil in slowing the aggregation of amyloid plaques associated with that form of progressive dementia.
Fourth Amendment advocates win big in Lange v. California.
A social media struggle in the New Hampshire L.P. fractured a state party and triggered a national meltdown.
A training session for graduate students urged them to prohibit students from discussing problematic views.
"I didn't think it was a big deal," says Kim Blalock. "My son is perfectly fine."